IAM
Innovis Asset Management Portfolio holdings
AUM
$260M
This Quarter Return
+10.77%
1 Year Return
+28.13%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$271M
AUM Growth
+$271M
(+9.8%)
Cap. Flow
-$615K
Cap. Flow
% of AUM
-0.23%
Top 10 Holdings %
Top 10 Hldgs %
35%
Holding
186
New
25
Increased
36
Reduced
83
Closed
24
Top Buys
| 1 |
DexCom
DXCM
|
$4.8M |
| 2 |
Rockwell Automation
ROK
|
$4.74M |
| 3 |
Emerson Electric
EMR
|
$3.66M |
| 4 |
Newmont
NEM
|
$3.24M |
| 5 |
Microsoft
MSFT
|
$3.19M |
Top Sells
| 1 |
Pfizer
PFE
|
$5.01M |
| 2 |
Freeport-McMoran
FCX
|
$3.32M |
| 3 |
Corteva
CTVA
|
$3.26M |
| 4 |
Devon Energy
DVN
|
$3.24M |
| 5 |
UnitedHealth
UNH
|
$2.64M |
Sector Composition
| 1 | Technology | 31.6% |
| 2 | Healthcare | 22.77% |
| 3 | Financials | 8.72% |
| 4 | Energy | 6.58% |
| 5 | Consumer Staples | 6.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DNB
126
DELISTED
Dun & Bradstreet
DNB
| $276K | 0.1% |
+23,896
| New | +$276K |
|
127
Cogent Biosciences
COGT
$1.83B
| $271K | 0.1% |
22,854
+133
| +0.6% | +$1.58K |
|
128
Verizon
VZ
$184B
| $270K | 0.1% |
+7,254
| New | +$270K |
|
|
RVNC
129
DELISTED
Revance Therapeutics, Inc.
RVNC
| $266K | 0.1% |
+10,517
| New | +$266K |
|
130
Schrodinger
SDGR
$1.42B
| $265K | 0.1% |
5,316
-4,712
| -47% | -$235K |
|
131
Toronto Dominion Bank
TD
$128B
| $261K | 0.1% |
4,216
-62
| -1% | -$3.85K |
|
132
Bank of Montreal
BMO
$88.5B
| $256K | 0.09% |
2,840
-39
| -1% | -$3.52K |
|
133
Chart Industries
GTLS
$8.94B
| $255K | 0.09% |
+1,595
| New | +$255K |
|
134
Erasca
ERAS
$406M
| $253K | 0.09% |
91,800
+48,363
| +111% | +$133K |
|
135
Walmart
WMT
$793B
| $251K | 0.09% |
1,600
| – | – |
|
136
Sempra
SRE
$53.7B
| $250K | 0.09% |
1,718
-20
| -1% | -$2.91K |
|
137
Pliant Therapeutics
PLRX
$105M
| $249K | 0.09% |
+13,762
| New | +$249K |
|
138
CDW
CDW
$21.4B
| $248K | 0.09% |
+1,350
| New | +$248K |
|
139
Goldman Sachs
GS
$221B
| $244K | 0.09% |
757
-4
| -0.5% | -$1.29K |
|
140
Tarsus Pharmaceuticals
TARS
$2.44B
| $237K | 0.09% |
13,141
+82
| +0.6% | +$1.48K |
|
141
Duke Energy
DUK
$94.5B
| $237K | 0.09% |
2,642
-37
| -1% | -$3.32K |
|
142
Domo
DOMO
$586M
| $233K | 0.09% |
+15,893
| New | +$233K |
|
143
iShares Core S&P Mid-Cap ETF
IJH
$99.4B
| $230K | 0.09% |
880
| – | – |
|
144
Beyond Air
XAIR
$12.1M
| $229K | 0.08% |
53,721
+26,267
| +96% | +$112K |
|
|
SWTX
145
DELISTED
SpringWorks Therapeutics
SWTX
| $226K | 0.08% |
+8,613
| New | +$226K |
|
146
America Movil
AMX
$58.9B
| $220K | 0.08% |
10,172
-100
| -1% | -$2.16K |
|
147
Portillo's
PTLO
$488M
| $215K | 0.08% |
+9,522
| New | +$215K |
|
148
Noodles & Co
NDLS
$31M
| $207K | 0.08% |
61,368
+428
| +0.7% | +$1.45K |
|
149
MeiraGTx Holdings
MGTX
$590M
| $205K | 0.08% |
+30,496
| New | +$205K |
|
150
Dynavax Technologies
DVAX
$1.19B
| $198K | 0.07% |
+15,328
| New | +$198K |
|